The GLP is committed to full transparency. Download and review our 2019 Annual Report

More precise cancer treatments may be possible by pairing CRISPR with genetic sequencing

| | March 3, 2020
crispr genes
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

In search of new ways to sequence human genomes and read critical alterations in DNA, researchers have successfully used the gene cutting tool CRISPR to make cuts in DNA around lengthy tumour genes.

The researchers Johns Hopkins Medicine say this can be used to collect sequence information, and that pairing CRISPR with DNA sequencing tools, that sequence the DNA components of human cancer tissue, is a technique that could, one day, enable fast, relatively cheap, sequencing of patients’ tumours.

This could lead to streamlining the selection and use of cancer treatments that target highly specific and personal genetic alterations.

Winston Timp, PhD, assistant professor of biomedical engineering and molecular biology and genetics at the Johns Hopkins University School of Medicine, said: “For tumour sequencing in cancer patients, you don’t necessarily need to sequence the whole cancer genome. Deep sequencing of particular areas of genetic interest can be very informative.”

Related article:  Should Europe's 17-year-old GMO regulations apply to CRISPR-edited crops?

In addition to its potential to guide treatment for patients, Timp says the combination of CRISPR technology and nanopore sequencing provides such depth that it may help scientists find new disease-linked gene alterations specific to one allele (inherited from one parent) and not another.

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend